# Millerknoll, Inc.: financial statements, quarterly MLKN · Nasdaq · CIK 66382 · [Materials](/sectors/materials.md) · fiscal year ends May 29 Pages: [Overview](/companies/mlkn.md) · [Financials](/companies/mlkn/financials.md) · [Filings](/companies/mlkn/filings.md) · [Insiders](/companies/mlkn/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mlkn/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [950](/filings/0000066382-25-000007.md) | [872](/filings/0000066382-25-000027.md) | [889 d](/filings/0000066382-26-000092.md) | [862](/filings/0000066382-25-000112.md) | [970](/filings/0000066382-26-000010.md) | [876](/filings/0000066382-26-000050.md) | [962 d](/filings/0000066382-26-000092.md) | [956](/filings/0000066382-26-000156.md) | [955](/filings/0000066382-26-000010.md) | [927](/filings/0000066382-26-000050.md) | [1,004 d](/filings/0000066382-26-000092.md) | [923](/filings/0000066382-26-000156.md) | | Cost of revenue | $m | [578](/filings/0000066382-25-000007.md) | [535](/filings/0000066382-25-000027.md) | [537 d](/filings/0000066382-26-000092.md) | [525](/filings/0000066382-25-000112.md) | [593](/filings/0000066382-26-000010.md) | [544](/filings/0000066382-26-000050.md) | [585 d](/filings/0000066382-26-000092.md) | [588](/filings/0000066382-26-000156.md) | [583](/filings/0000066382-26-000010.md) | [574](/filings/0000066382-26-000050.md) | [609 d](/filings/0000066382-26-000092.md) | [538](/filings/0000066382-26-000156.md) | | Gross profit | $m | [372](/filings/0000066382-25-000007.md) | [337](/filings/0000066382-25-000027.md) | [352 d](/filings/0000066382-26-000092.md) | [336](/filings/0000066382-25-000112.md) | [377](/filings/0000066382-26-000010.md) | [332](/filings/0000066382-26-000050.md) | [377 d](/filings/0000066382-26-000092.md) | [368](/filings/0000066382-26-000156.md) | [372](/filings/0000066382-26-000010.md) | [353](/filings/0000066382-26-000050.md) | [396 d](/filings/0000066382-26-000092.md) | [385](/filings/0000066382-26-000156.md) | | Research and development | $m | [22.2](/filings/0000066382-25-000007.md) | [21.4](/filings/0000066382-25-000027.md) | [26.9 d](/filings/0000066382-26-000092.md) | [22.7](/filings/0000066382-25-000112.md) | [24.6](/filings/0000066382-26-000010.md) | [22.3](/filings/0000066382-26-000050.md) | [24.2 d](/filings/0000066382-26-000092.md) | [20.3](/filings/0000066382-26-000156.md) | [24.0](/filings/0000066382-26-000010.md) | [20.6](/filings/0000066382-26-000050.md) | [35.4 d](/filings/0000066382-26-000092.md) | [25.0](/filings/0000066382-26-000156.md) | | Selling, general and administrative | $m | [288](/filings/0000066382-25-000007.md) | [271](/filings/0000066382-25-000027.md) | [263 d](/filings/0000066382-26-000092.md) | [298](/filings/0000066382-25-000112.md) | [290](/filings/0000066382-26-000010.md) | [258](/filings/0000066382-26-000050.md) | [287 d](/filings/0000066382-26-000092.md) | [294](/filings/0000066382-26-000156.md) | [298](/filings/0000066382-26-000010.md) | [286](/filings/0000066382-26-000050.md) | [301 d](/filings/0000066382-26-000092.md) | [303](/filings/0000066382-26-000156.md) | | Operating income | $m | [60.4](/filings/0000066382-25-000007.md) | [42.8](/filings/0000066382-25-000027.md) | [23.7 d](/filings/0000066382-26-000092.md) | [15.2](/filings/0000066382-25-000112.md) | [62.5](/filings/0000066382-26-000010.md) | [(82.2)](/filings/0000066382-26-000050.md) | [55.0 d](/filings/0000066382-26-000092.md) | [53.5](/filings/0000066382-26-000156.md) | [48.5](/filings/0000066382-26-000010.md) | [44.9](/filings/0000066382-26-000050.md) | [51.4 d](/filings/0000066382-26-000092.md) | [51.8](/filings/0000066382-26-000156.md) | | Interest expense | $m | [19.8](/filings/0000066382-24-000004.md) | [18.4](/filings/0000066382-24-000014.md) | [18.8 d](/filings/0000066382-26-000092.md) | [19.9](/filings/0000066382-25-000112.md) | [20.4](/filings/0000066382-26-000010.md) | [19.1](/filings/0000066382-26-000050.md) | [17.3 d](/filings/0000066382-26-000092.md) | [18.4](/filings/0000066382-26-000156.md) | [17.9](/filings/0000066382-26-000010.md) | [17.2](/filings/0000066382-26-000050.md) | [16.4 d](/filings/0000066382-26-000092.md) | [16.2](/filings/0000066382-26-000156.md) | | Income tax | $m | [9.5](/filings/0000066382-25-000007.md) | [4.4](/filings/0000066382-25-000027.md) | [(4.3) d](/filings/0000066382-26-000092.md) | [(1.1)](/filings/0000066382-25-000112.md) | [9.8](/filings/0000066382-26-000010.md) | [(89.0)](/filings/0000066382-26-000050.md) | [91.9 d](/filings/0000066382-26-000092.md) | [7.6](/filings/0000066382-26-000156.md) | [7.3](/filings/0000066382-26-000010.md) | [5.6](/filings/0000066382-26-000050.md) | [11.9 d](/filings/0000066382-26-000092.md) | [7.6](/filings/0000066382-26-000156.md) | | Net income | $m | [33.5](/filings/0000066382-25-000027.md) | [22.2](/filings/0000066382-25-000027.md) | [9.9 d](/filings/0000066382-26-000092.md) | [(1.2)](/filings/0000066382-26-000050.md) | [34.1](/filings/0000066382-26-000050.md) | [(12.7)](/filings/0000066382-26-000050.md) | [(57.1) d](/filings/0000066382-26-000092.md) | [20.2](/filings/0000066382-26-000156.md) | [24.2](/filings/0000066382-26-000050.md) | [23.5](/filings/0000066382-26-000050.md) | [23.6 d](/filings/0000066382-26-000092.md) | [26.6](/filings/0000066382-26-000156.md) | | Diluted EPS | $ per share | [0.45](/filings/0000066382-25-000007.md) | [0.30](/filings/0000066382-25-000027.md) | not reported | [(0.02)](/filings/0000066382-25-000112.md) | [0.49](/filings/0000066382-26-000010.md) | [(0.19)](/filings/0000066382-26-000050.md) | not reported | [0.29](/filings/0000066382-26-000156.md) | [0.35](/filings/0000066382-26-000010.md) | [0.34](/filings/0000066382-26-000050.md) | not reported | [0.38](/filings/0000066382-26-000156.md) | | Basic EPS | $ per share | [0.45](/filings/0000066382-25-000007.md) | [0.31](/filings/0000066382-25-000027.md) | not reported | [(0.02)](/filings/0000066382-25-000112.md) | [0.49](/filings/0000066382-26-000010.md) | [(0.19)](/filings/0000066382-26-000050.md) | not reported | [0.29](/filings/0000066382-26-000156.md) | [0.35](/filings/0000066382-26-000010.md) | [0.34](/filings/0000066382-26-000050.md) | not reported | [0.38](/filings/0000066382-26-000156.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | [194](/filings/0000066382-26-000092.md) | [167](/filings/0000066382-25-000112.md) | [180](/filings/0000066382-26-000010.md) | [175](/filings/0000066382-26-000050.md) | [168](/filings/0000066382-26-000156.md) | [179](/filings/0000066382-26-000156.md) | | Current assets | $m | [1,114](/filings/0000066382-24-000004.md) | [1,083](/filings/0000066382-24-000014.md) | [1,070](/filings/0000066382-25-000069.md) | [1,072](/filings/0000066382-24-000084.md) | [1,126](/filings/0000066382-25-000007.md) | [1,141](/filings/0000066382-25-000027.md) | [1,109](/filings/0000066382-26-000092.md) | [1,090](/filings/0000066382-25-000112.md) | [1,118](/filings/0000066382-26-000010.md) | [1,122](/filings/0000066382-26-000050.md) | [1,137](/filings/0000066382-26-000156.md) | [1,140](/filings/0000066382-26-000156.md) | | Total assets | $m | [4,156](/filings/0000066382-24-000004.md) | [4,095](/filings/0000066382-24-000014.md) | [4,044](/filings/0000066382-25-000069.md) | [4,019](/filings/0000066382-24-000084.md) | [4,036](/filings/0000066382-25-000007.md) | [3,895](/filings/0000066382-25-000027.md) | [3,950](/filings/0000066382-26-000092.md) | [3,941](/filings/0000066382-25-000112.md) | [3,946](/filings/0000066382-26-000010.md) | [3,952](/filings/0000066382-26-000050.md) | [4,001](/filings/0000066382-26-000156.md) | [4,003](/filings/0000066382-26-000156.md) | | Current liabilities | $m | [714](/filings/0000066382-24-000004.md) | [681](/filings/0000066382-24-000014.md) | [698](/filings/0000066382-25-000069.md) | [676](/filings/0000066382-24-000084.md) | [704](/filings/0000066382-25-000007.md) | [683](/filings/0000066382-25-000027.md) | [704](/filings/0000066382-26-000092.md) | [652](/filings/0000066382-25-000112.md) | [672](/filings/0000066382-26-000010.md) | [682](/filings/0000066382-26-000050.md) | [721](/filings/0000066382-26-000156.md) | [692](/filings/0000066382-26-000156.md) | | Total liabilities | $m | [2,625](/filings/0000066382-24-000004.md) | [2,597](/filings/0000066382-24-000014.md) | [2,585](/filings/0000066382-25-000069.md) | [2,610](/filings/0000066382-24-000084.md) | [2,652](/filings/0000066382-25-000007.md) | [2,573](/filings/0000066382-25-000027.md) | [2,615](/filings/0000066382-26-000092.md) | [2,579](/filings/0000066382-25-000112.md) | [2,584](/filings/0000066382-26-000010.md) | [2,553](/filings/0000066382-26-000050.md) | [2,595](/filings/0000066382-26-000156.md) | [2,583](/filings/0000066382-26-000156.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [200](/filings/0000066382-26-000050.md) | not reported | not reported | | Current portion of debt | $m | [38.8](/filings/0000066382-24-000004.md) | [40.9](/filings/0000066382-24-000014.md) | [43.5](/filings/0000066382-25-000069.md) | [45.9](/filings/0000066382-24-000084.md) | [48.7](/filings/0000066382-25-000007.md) | [48.4](/filings/0000066382-25-000027.md) | [16.0](/filings/0000066382-26-000092.md) | [16.4](/filings/0000066382-25-000112.md) | [20.7](/filings/0000066382-26-000010.md) | [22.6](/filings/0000066382-26-000050.md) | [25.1](/filings/0000066382-26-000156.md) | [28.4](/filings/0000066382-26-000156.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,421](/filings/0000066382-25-000027.md) | [1,391](/filings/0000066382-25-000027.md) | [1,385](/filings/0000066382-26-000092.md) | [1,333](/filings/0000066382-26-000050.md) | [1,311](/filings/0000066382-26-000050.md) | [1,254](/filings/0000066382-26-000050.md) | [1,276](/filings/0000066382-26-000156.md) | [1,300](/filings/0000066382-26-000156.md) | [1,300](/filings/0000066382-26-000050.md) | [1,336](/filings/0000066382-26-000050.md) | [1,343](/filings/0000066382-26-000156.md) | [1,356](/filings/0000066382-26-000156.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q4 FY2024 (2024-06-01) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-30) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [82.5 d](/filings/0000066382-25-000007.md) | [60.5 d](/filings/0000066382-25-000027.md) | [78.4 d](/filings/0000066382-26-000092.md) | [21.1](/filings/0000066382-25-000112.md) | [55.3 d](/filings/0000066382-26-000010.md) | [62.0 d](/filings/0000066382-26-000050.md) | [70.9 d](/filings/0000066382-26-000092.md) | [9.4](/filings/0000066382-26-000156.md) | [64.6 d](/filings/0000066382-26-000010.md) | [61.1 d](/filings/0000066382-26-000050.md) | [64.8 d](/filings/0000066382-26-000092.md) | [49.1](/filings/0000066382-26-000156.md) | | Capital expenditure | $m | [20.0 d](/filings/0000066382-25-000007.md) | [16.6 d](/filings/0000066382-25-000027.md) | [21.9 d](/filings/0000066382-26-000092.md) | [22.6](/filings/0000066382-25-000112.md) | [22.3 d](/filings/0000066382-26-000010.md) | [23.2 d](/filings/0000066382-26-000050.md) | [39.5 d](/filings/0000066382-26-000092.md) | [30.7](/filings/0000066382-26-000156.md) | [30.6 d](/filings/0000066382-26-000010.md) | [22.1 d](/filings/0000066382-26-000050.md) | [38.9 d](/filings/0000066382-26-000092.md) | [32.5](/filings/0000066382-26-000156.md) | | Dividends paid | $m | [13.9 d](/filings/0000066382-25-000007.md) | [14.1 d](/filings/0000066382-25-000027.md) | [13.4 d](/filings/0000066382-26-000092.md) | [13.2](/filings/0000066382-25-000112.md) | [13.0 d](/filings/0000066382-26-000010.md) | [12.8 d](/filings/0000066382-26-000050.md) | [12.7 d](/filings/0000066382-26-000092.md) | [12.7](/filings/0000066382-26-000156.md) | [12.9 d](/filings/0000066382-26-000010.md) | [12.7 d](/filings/0000066382-26-000050.md) | [12.8 d](/filings/0000066382-26-000092.md) | [12.8](/filings/0000066382-26-000156.md) | | Share repurchases | $m | [28.0 d](/filings/0000066382-25-000007.md) | [41.0 d](/filings/0000066382-25-000027.md) | [37.2 d](/filings/0000066382-25-000069.md) | [43.7](/filings/0000066382-24-000084.md) | [23.2 d](/filings/0000066382-25-000007.md) | [17.9 d](/filings/0000066382-25-000027.md) | [0.1 d](/filings/0000066382-25-000069.md) | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-12-03) | Q3 FY2023 (2023-03-04) | Q1 FY2024 (2023-09-02) | Q2 FY2024 (2023-12-02) | Q3 FY2024 (2024-03-02) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-03-01) | Q1 FY2026 (2025-08-30) | Q2 FY2026 (2025-11-29) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-29) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [75.9](/filings/0000066382-24-000004.md) | [76.1](/filings/0000066382-24-000014.md) | [75.7](/filings/0000066382-24-000084.md) | [74.2](/filings/0000066382-25-000007.md) | [74.1](/filings/0000066382-25-000027.md) | [70.2](/filings/0000066382-25-000112.md) | [70.0](/filings/0000066382-26-000010.md) | [68.4](/filings/0000066382-26-000050.md) | [69.2](/filings/0000066382-26-000156.md) | [68.9](/filings/0000066382-26-000010.md) | [69.1](/filings/0000066382-26-000050.md) | [70.0](/filings/0000066382-26-000156.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 68,799,795 at 2026-09-25, from the cover of the [10-Q filed 2026-09-28](/filings/0000066382-26-000156.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.